Sionna Therapeutics, Inc. (NasdaqGM: SION)
Health Care · Biotechnology · US
$5.29
-4.17% today · -78.3% 1Y
Sionna Therapeutics, Inc. (NasdaqGM: SION) operates in the Biotechnology industry within the Health Care sector. The company is valued at $239.17M and employs 59 people.
Over the last twelve months the share price has lost 78.3%, trading between 4.01 and 54.97.
Tweenvest scores Sionna Therapeutics, Inc. across four factors: quality 28/100. Its strongest factor is quality.
SION price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $239.17M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.17
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $54.97
- 52-week low
- $4.01
- Avg volume (3M)
- —
- Shares outstanding
- 45.21M
- Employees
- 59
- Next earnings
- —
About Sionna Therapeutics, Inc.
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
- Founded
- 2019
- Listed since
- Feb 7, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.